• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu .

作者信息

Salvarani Carlo, Bajocchi Gianluigi, Mancuso Pamela, Galli Elena, Muratore Francesco, Giorgi Rossi Paolo

机构信息

Unit of Rheumatology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy

University of Modena and Reggio Emilia, Modena, Italy.

出版信息

Ann Rheum Dis. 2021 Jun;80(6):e96. doi: 10.1136/annrheumdis-2020-218364. Epub 2020 Jul 6.

DOI:10.1136/annrheumdis-2020-218364
PMID:32632030
Abstract
摘要

相似文献

1
Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu .
Ann Rheum Dis. 2021 Jun;80(6):e96. doi: 10.1136/annrheumdis-2020-218364. Epub 2020 Jul 6.
2
COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study.接受b/tsDMARDs治疗的儿科风湿病患者中的COVID-19：一项横断面患者调查研究。
Ann Rheum Dis. 2021 Jun;80(6):e95. doi: 10.1136/annrheumdis-2020-218341. Epub 2020 Jul 6.
3
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.COVID-19 在接受靶向生物制剂和合成疾病修饰抗风湿药物治疗的成人和儿科风湿性疾病患者队列中的发病率。
Semin Arthritis Rheum. 2020 Aug;50(4):564-570. doi: 10.1016/j.semarthrit.2020.05.001. Epub 2020 May 16.
4
The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi .2019冠状病毒病治疗靶点的难题：与风湿病学的密切关联。回应：古普塔所著的《2019冠状病毒病大流行期间的风湿病管理：印度风湿病从业者的观点》以及卡佩奇所著的《2019冠状病毒病中的抗风湿药物：白细胞介素-6是正确的靶点吗？》
Ann Rheum Dis. 2021 Jan;80(1):e3. doi: 10.1136/annrheumdis-2020-217545. Epub 2020 Apr 27.
5
How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?COVID-19 大流行如何影响我们使用生物/靶向 DMARDs 的风湿病患者？
J Infect Dev Ctries. 2023 Jul 27;17(7):944-952. doi: 10.3855/jidc.17470.
6
How the COVID-19 pandemic has influenced pediatric rheumatology practice: Results of a global, cross-sectional, online survey.COVID-19 大流行如何影响儿科风湿病学实践：一项全球、横断面、在线调查的结果。
Semin Arthritis Rheum. 2020 Dec;50(6):1262-1268. doi: 10.1016/j.semarthrit.2020.09.008. Epub 2020 Sep 28.
7
Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases.系统治疗对免疫介导性疾病患者 SARS-CoV-2 抗体血清阳性率的影响。
Med Clin (Barc). 2024 May 31;162(10):470-476. doi: 10.1016/j.medcli.2023.12.011. Epub 2024 Feb 27.
8
Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany.儿童和青少年风湿性肌肉骨骼疾病患者感染 SARS-CoV-2 的临床表现和结局：来自德国国家儿科风湿病数据库的数据。
RMD Open. 2021 Jul;7(2). doi: 10.1136/rmdopen-2021-001687.
9
Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.德国风湿病学会（DGRh eV）关于SARS-CoV-2/COVID-19大流行期间炎性风湿性疾病患者管理的初步建议。
Ann Rheum Dis. 2020 Jun;79(6):840-842. doi: 10.1136/annrheumdis-2020-217628. Epub 2020 Apr 28.
10
Editorial: Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care.社论：2019冠状病毒病中的风湿病学：发病机制、治疗与临床护理
Curr Opin Rheumatol. 2021 Sep 1;33(5):409-411. doi: 10.1097/BOR.0000000000000813.